Search Results - "Abernethy, David"

The latitude gradient for multiple sclerosis prevalence is established in the early life course by Sabel, Clive E, Pearson, John F, Mason, Deborah F, Willoughby, Ernest, Abernethy, David A, Taylor, Bruce V

“…Abstract The strongest epidemiological clue that the environment at the population level has a significant impact on the risk of developing multiple sclerosis…”
Get full text

Is Implicit Sequence Learning Impaired in Parkinson's Disease? A Meta-Analysis by Siegert, Richard J, Taylor, Kathryn D, Weatherall, Mark, Abernethy, David A

“…The aim of the present study was to examine impairment of implicit learning in Parkinson's disease (PD) by means of a meta-analysis of studies that used the…”
Get full text

MS prevalence in New Zealand, an ethnically and latitudinally diverse country by Taylor, Bruce V, Pearson, John F, Clarke, Glynnis, Mason, Deborah F, Abernethy, David A, Willoughby, Ernie, Sabel, Clive

“…Background: The prevalence of multiple sclerosis (MS) is not uniform, with a latitudinal gradient of prevalence present in most studies. Understanding the…”
Get full text

The effect of Parkinson’s disease on time estimation as a function of stimulus duration range and modality by Smith, Jared G., Harper, David N., Gittings, David, Abernethy, David

“…The present research sought to investigate the role of the basal ganglia in timing of sub- and supra-second intervals via an examination of the ability of…”
Get full text

A Meta-Analysis of Performance on Simple Span and More Complex Working Memory Tasks in Parkinson's Disease by Siegert, Richard J, Weatherall, Mark, Taylor, Kathryn D, Abernethy, David A

“…The working memory (WM) concept has stimulated substantial research since Baddeley and Hitch advanced their model in 1974. There has also been growing interest…”
Get full text

An investigation of the relationship between latitude and multiple sclerosis severity in New Zealand by Alla, Sridhar, Pearson, John F, Taylor, Bruce V, Roxburgh, Richard, Clarke, Glynnis, Miller, David H, Richardson, Ann, Abernethy, David A, Willoughby, Ernie, Sabel, Clive E, Mason, Deborah F

Get full text

Safety and acceptability of clozapine and risperidone in progressive multiple sclerosis: a phase I, randomised, blinded, placebo-controlled trial by La Flamme, Anne C, Abernethy, David, Sim, Dalice, Goode, Liz, Lockhart, Michelle, Bourke, David, Milner, Imogen, Garrill, Toni-Marie, Joshi, Purwa, Watson, Eloise, Smyth, Duncan, Lance, Sean, Connor, Bronwen

“…ObjectiveBecause clozapine and risperidone have been shown to reduce neuroinflammation in humans and mice, the Clozapine and Risperidone in Progressive…”
Get full text

Disability profile of multiple sclerosis in New Zealand by Alla, Sridhar, Pearson, John F, Taylor, Bruce V, Miller, David H, Clarke, Glynnis, Richardson, Ann, Willoughby, Ernie, Abernethy, David A, Sabel, Clive E, Mason, Deborah F

“…Highlights • New Zealand is a high risk region for MS. • Higher disability is seen in those with longer disease duration, spinal cord syndromes with motor…”
Get full text

Atypical presentations of immune‐mediated necrotizing myopathy: Clues and caveats by Joshi, Purwa, Abernethy, David

Get full text

K rishan K umar . Visions of Empire: How Five Imperial Regimes Changed the World by Abernethy, David B.

Get full text

Quality of diagnostic coding and information flow from hospital to general practice by Kljakovic, Marjan, Abernethy, David, de Ruiter, Ingrid

“…To describe the transfer of patient information from hospital to general practice and compare the quality of coding of patient diagnoses in hospital and…”
Get full text

10. Subclinical orbicularis oculi spasm can mimic ptosis due to myasthenia gravis by Joshi, Purwa, Abernethy, David, Cruse, Belinda, Day, Timothy

Get full text

Expansion and preferential activation of the CD14+CD16+ monocyte subset during multiple sclerosis by Chuluundorj, Delgertsetseg, Harding, Scott A, Abernethy, David, La Flamme, Anne Camille

“…Multiple sclerosis (MS) is an immune‐driven, demyelinating disease of the central nervous system (CNS). Although many types of immune cells are involved in…”
Get full text

2359 Optimising patient selection for muscle biopsy in a general neurology setting by Scott, Imogene, Abernethy, David, Joshi, Purwa

“…ObjectivesWe aimed to assess the diagnostic utility of a muscle biopsy in a general neurology setting, and to identify strategies to improve patient…”
Get full text

Rehabilitation Outcomes of Patients with Severe Strokes (P3.305) by Joshi, Purwa, Abernethy, David, McNaughton, Harry

“…Abstract only…”
Get full text

Multiple sclerosis mortality in New Zealand: a nationwide prospective study by Leadbetter, Ruth, MacAskill, Michael, Myall, Daniell J, Taylor, Bruce V, Joshi, Purwa, Mason, Deborah F, Pearson, John F, Clarke, Glynnis, Abernethy, David A, Willoughby, Ernest, Sabel, Clive E

“…BackgroundMortality data from Europe and North America show a shorter life expectancy for people with multiple sclerosis (MS). It is not known if a similar…”
Get full text

Glatiramer acetate treatment normalized the monocyte activation profile in MS patients to that of healthy controls by Chuluundorj, Delgertsetseg, Harding, Scott A, Abernethy, David, La Flamme, Anne Camille

“…Multiple sclerosis (MS) is an immune‐mediated disease of the central nervous system, and monocytes contribute to MS‐associated neuroinflammation. While…”
Get full text

Vitamin D did not reduce multiple sclerosis disease activity after a clinically isolated syndrome by Butzkueven, Helmut, Ponsonby, Anne-Louise, Stein, Mark S, Lucas, Robyn M, Mason, Deborah, Broadley, Simon, Kilpatrick, Trevor, Lechner-Scott, Jeannette, Barnett, Michael, Carroll, William, Mitchell, Peter, Hardy, Todd A, Macdonell, Richard, McCombe, Pamela, Lee, Andrew, Kalincik, Tomas, van der Walt, Anneke, Lynch, Chris, Abernethy, David, Willoughby, Ernest, Barkhof, Frederik, MacManus, David, Clarke, Michael, Andrew, Julie, Morahan, Julia, Zhu, Chao, Dear, Keith, Taylor, Bruce V

“…Low serum levels of 25-hydroxyvitamin D [25(OH)D] and low sunlight exposure are known risk factors for the development of multiple sclerosis. Add-on vitamin D…”
Get full text

An electronic decision support tool for Stroke Prevention in Atrial Fibrillation (SPAF): An integrated primary-tertiary care model of care. (S47.001) by Jolliffe, Evan, Rosemergy, Ian, Lanford, Jeremiah, Abernethy, David, Ranta, Annemarei

“…Abstract only…”
Get full text

A dedicated Stroke Prevention in Atrial Fibrillation (SPAF) clinic for the acute assessment and initiation of anticoagulation in patients with atrial fibrillation. (P1.056) by Jolliffe, Evan, Rosemergy, Ian, Lanford, Jeremiah, Abernethy, David

“…Abstract only…”
Get full text